Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0725 |
| Open | 0.0725 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0725 - 0.0725 |
| 52 Week Range | 0.0020 - 0.2900 |
| Volume | 2,100 |
| Avg. Volume | 17,981 |
| Market Cap | 44,537 |
| Beta (5Y Monthly) | -0.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -695.6780 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Moody's
Indiana Regional Med.Ctr., PA -- Moody's downgrades Indiana Regional Medical Center (PA) to Ba3; negative outlook
Moody's Investors Service has downgraded Indiana Regional Medical Center's (PA) revenue bond rating to Ba3 from Ba2. The downgrade to Ba3 reflects Indiana Regional Medical Center's (IRMC) weak operating performance in fiscal 2020, in part due to COVID-19, and an expectation that margins will remain at levels that show variance to budget. The impact of the suspension of non-essential services during COVID-19 on IRMC's revenue base, a social risk under Moody's ESG classification, will create a larger hurdle to improve and restore profitability.
© 2021 Verizon Media. All rights reserved.
